Health

Gynecology Drug Market Players Focus On Developing Effe...

TBRC’s market research report covers gynecology drugs market size, gynecology dr...

L'Association canadienne du vapotage : Les jeunes et le...

BEAMSVILLE, Ontario, 02 juin 2022 (GLOBE NEWSWIRE) -- Un article d'opinion, in...

The Canadian Vaping Association: British Columbia’s you...

BEAMSVILLE, Ontario, June 02, 2022 (GLOBE NEWSWIRE) -- An op-ed, Why is plain...

Pulse Oximeter Market to hit USD 2.5 Billion by 2030, s...

Some of the major market players operating in the pulse oximeter industry includ...

Cytokinetics Announces Inducement Grants Under Nasdaq L...

SOUTH SAN FRANCISCO, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, I...

Kinnate Biopharma Inc. to Participate in Upcoming Inves...

SAN FRANCISCO and SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopha...

Aclaris Therapeutics to Participate in the Jefferies He...

WAYNE, Pa., June 01, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASD...

Cytek Biosciences to Host Inaugural Analyst and Investo...

FREMONT, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“...

Wellbeing Digital Sciences’ Dr. Corey Hilmas Invited to...

Dr. Hilmas will Represent the Company at the IPA World Congress and Probiota Ame...

Viridian Therapeutics to Participate in June Investor C...

WALTHAM, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. ...

CinCor Pharma Doses First Patient in Phase 2 FigHTN-CKD...

figHTN-CKD is CinCor’s fourth ongoing Phase 2 clinical trial evaluating baxdrost...

Adamis Pharmaceuticals Provides Update on Clinical Stud...

DSMB Has Reviewed Interim Clinical and Safety Data and Recommended that the Stud...

Cornerstone Pharmaceuticals to Present Pancreatic Cance...

Cranbury, NJ, June 01, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, I...

Akoya Biosciences to Highlight Novel Spatial Transcript...

PhenoCycler™-Fusion will enable single-cell, whole-slide spatial multiomic capab...

New Data from Clene’s RESCUE-ALS Study to be Presented ...

SALT LAKE CITY, June 01, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) al...

ALX Oncology to Participate in the Jefferies 2022 Healt...

SOUTH SAN FRANCISCO, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- ALX Oncology Ho...